Compare Moderna, Inc. (MRNA) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Pinterest Inc — how do they compare? Moderna, Inc. trades at $221.45 (market cap $78.65B), while Pinterest Inc trades at $21.4 (market cap $11.63B). The key difference: Moderna, Inc. is far larger — about 6.8× Pinterest Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Pinterest Inc for 85 Days on average.
| MRNA | PINS | |
|---|---|---|
Market Cap | $78.65B | $11.63B |
Volume | 37,373,437 | 12,792,940 |
Sector | Health | Media |
52-Week High | $203.46 | $35.24 |
52-Week Low | $22.36 | $15.42 |
Typical Hold Time | 59 Days | 85 Days |
Enterprise Value | $74.80B | $11.55B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $214.50, up 9.17% with strong technical momentum. The stock shows bullish moving average signals despite negative profitability metrics, with revenue declining from $18.9B in 2022 to $1.92B in 2025. Recent Nasdaq-100 inclusion creates institutional demand, though Citigroup downgraded to Sell citing valuation concerns after a 500% 2026 rally. The company continues beating EPS expectations despite net losses.
Outlook remains bifurcated between technical strength and fundamental challenges. The cancer vaccine pipeline offers growth potential, but persistent losses and high valuations create headwinds. Near-term momentum may continue from index fund inflows, though profitability concerns warrant caution for long-term investors.
Pinterest (PINS) trades at $21.35, up 5.1% today, showing strong momentum after three consecutive earnings beats. The stock maintains a bullish technical outlook with positive moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, revenue growth accelerated to $4.22 billion in 2025 with improving profitability, though valuation multiples remain elevated with a P/E of 60.4. Recent news highlights the company's visual search ad innovations and international monetization progress.
The outlook remains positive with 54% analyst buy ratings and a $27.93 consensus price target representing 31% upside. Key opportunities include continued international ARPU growth and AI-driven advertising enhancements. Risks include competitive pressure from larger platforms, potential advertising slowdowns, and insider selling activity that may signal caution among company leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
